Literature DB >> 1593394

Neurodevelopment in infants and preschool children with congenital hypothyroidism: etiological and treatment factors affecting outcome.

J F Rovet1, R M Ehrlich, D L Sorbara.   

Abstract

Studied global intelligence and specific abilities of children from 1 to 5 years old, 108 with congenital hypothyroidism (CH) diagnosed by newborn screening and 71 sibling controls. Intelligence levels of the CH group were within the normal range but differed significantly from controls at age 5. CH demonstrated a language deficit at age 3, which diminished with age, as well as significantly poorer visuospatial and verbal skills at age 5. Children with absent thyroid glands or evidence of hypothyroidism in utero were outperformed by other CH children in most ability areas from 1 year on. Different components of ability were correlated with specific factors reflecting timing or duration of thyroid hormone deficiency, suggesting unique critical periods of thyroid hormone sensitivity for different specific cognitive abilities and their neural substrates. It is concluded that even though screened CH children are markedly improved by neonatal diagnosis, they are still at risk for subtle irreversible deficits, which depend on factors such as type, age at onset, and duration of disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593394     DOI: 10.1093/jpepsy/17.2.187

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  17 in total

Review 1.  Early-life exposure to EDCs: role in childhood obesity and neurodevelopment.

Authors:  Joseph M Braun
Journal:  Nat Rev Endocrinol       Date:  2016-11-18       Impact factor: 43.330

2.  Speech impairment in primary hypothyroidism.

Authors:  A Mohammadzadeh; E Heydari; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-06       Impact factor: 4.256

3.  The National Register of infants with congenital hypothyroidism detected by neonatal screening in Italy.

Authors:  M Sorcini; P Balestrazzi; M E Grandolfo; S Carta; G Giovannelli
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

4.  Newborn thyroxine levels and childhood ADHD.

Authors:  Offie Porat Soldin; Arvind K N Nandedkar; Knoxley M Japal; Mark Stein; Shiela Mosee; Phyllis Magrab; Shenghan Lai; Steven H Lamm
Journal:  Clin Biochem       Date:  2002-03       Impact factor: 3.281

Review 5.  Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.

Authors:  L Bartalena; F Bogazzi; L E Braverman; E Martino
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

6.  Late intellectual and academic outcomes following traumatic brain injury sustained during early childhood.

Authors:  Linda Ewing-Cobbs; Mary R Prasad; Larry Kramer; Charles S Cox; James Baumgartner; Stephen Fletcher; Donna Mendez; Marcia Barnes; Xiaoling Zhang; Paul Swank
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

7.  Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.

Authors:  S Grosso; R Berardi; M Cioni; G Morgese
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

8.  Lack of a relation between human neonatal thyroxine and pediatric neurobehavioral disorders.

Authors:  Offie Porat Soldin; Shenghan Lai; Steven H Lamm; Shiela Mosee
Journal:  Thyroid       Date:  2003-02       Impact factor: 6.568

9.  Associations of early life urinary triclosan concentrations with maternal, neonatal, and child thyroid hormone levels.

Authors:  Joseph M Braun; Aimin Chen; Andrew Hoofnagle; George D Papandonatos; Medina Jackson-Browne; Russ Hauser; Megan E Romano; Margaret R Karagas; Kimberly Yolton; R Thomas Zoeller; Bruce P Lanphear
Journal:  Horm Behav       Date:  2017-12-06       Impact factor: 3.587

Review 10.  Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management.

Authors:  Malcolm Donaldson; Jeremy Jones
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.